title: [Medication of the month. Lowette, a contraceptive for treating acne in young women].
abstract: Acne is a multifactorial disorder affecting the vast majority of adolescents and young adults. Among the therapeutic armamentum, estroprogestative contraception can be offered to young women. The choice must, however, be carefully targeted because the estroprogestative associations do not show similar anti-acne efficacy. A new contraceptive associating 20 micrograms of ethinyl estradiol and 100 micrograms of levonorgestrel (Lowette) has proven its clinical efficacy in this indication.
authors.affiliation: CHU du Sart Tilman, Service de Dermatopathologie.
authors.forename: V
authors.initials: V
authors.lastname: Goffin
authors.forename: C
authors.initials: C
authors.lastname: Piérard-Franchimont
authors.forename: G E
authors.initials: GE
authors.lastname: Piérard
mesh_terms: D000152:Acne Vulgaris / Q000188:drug therapy*; D003280:Contraceptives, Oral, Synthetic / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D045166:Estradiol Congeners / Q000627:therapeutic use*; D004997:Ethinyl Estradiol / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D016912:Levonorgestrel / Q000627:therapeutic use*
chemical_list: D003280:Contraceptives, Oral, Synthetic; D045166:Estradiol Congeners; D004997:Ethinyl Estradiol; D016912:Levonorgestrel